Roopa Industries Ltd.

59.20 +0.84 ▲1.4%

28 March 2024, 04:01:00 PM
Volume: 2,074

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.investorsatril.com
Market Cap 46.55 Cr.
Enterprise Value(EV) 65.32 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 1.65 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 35.97 Trailing Twelve Months Ending 2023-12
Industry PE 41.54 Trailing Twelve Months Ending 2023-12
Book Value / Share 19.08 Trailing Twelve Months Ending 2023-12
Price to Book Value 3.10 Calculated using Price: 59.18
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.79 Cr. 7,865,520 Shares
FaceValue 10
About Roopa Industries Ltd.
Roopa Industries is a part of the TGV Group, a reputed conglomerate in India, which manufactures and exports Chloro Alkali Products, Castor Oil Derivatives, Fatty Acids and Water Treatment Chemicals to various countries. The company is a manufacturer of Neutraceuticals, Fine chemicals, Drug Intermediates and Bulk Drugs since 1998.

Roopa Industries Ltd. Delivery

Delivered Qty
Traded Qty

Roopa Industries Ltd. Performance

1 Day
+1.44%
1 Week
+6.71%
1 Month
+2.16%
3 Month
+24.87%
6 Month
+40.95%
1 Year
+39.52%
2 Year
+129.46%
5 Year
+439.16%
10 Year
+495.57%

Roopa Industries Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 1.88 1.96 2.07 5.63 5.97 3.51 6.41 8.41 10.17
Return on Capital Employed (%) 9.25 10.06 10.27 6.44 8.63 8.67 8.06 10.37 12.73
Return on Assets (%) 0.65 0.68 0.7 1.68 1.68 1 1.69 2.13 2.56

Roopa Industries Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 9 9 9 10 10 11 12 13 14 15
Non Curr. Liab. 4 6 8 11 10 9 9 5 3 6
Curr. Liab. 13 10 11 15 16 19 26 31 40 38
Minority Int.
Equity & Liab. 26 25 29 35 36 38 46 49 57 59
Non Curr. Assets 10 8 7 9 11 11 11 11 14 15
Curr. Assets 16 17 21 26 25 27 36 38 42 44
Misc. Exp. not W/O
Total Assets 26 25 29 35 36 38 46 49 57 59

Roopa Industries Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 31 31 30 19 30 28 29 51 76 66
Other Income 0 3 0 5 0 1 0 0 1 1
Total Income 31 34 30 24 30 29 29 51 77 67
Total Expenditure -29 -31 -28 -22 -28 -26 -26 -48 -72 -62
PBIDT 2 2 2 2 3 3 3 4 5 5
Interest -1 -1 -2 -1 -1 -1 -1 -1 -2 -3
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT 0 0 0 1 1 0 1 1 1 1
Adjusted EPS 0 0 0 1 1 0 1 1 2 2

Roopa Industries Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 1 1 1 -1 -5 4 2 -1 2 9
Cash Fr. Inv. 0 0 0 0 3 -2 1 1 4 -1
Cash Fr. Finan. 0 0 -1 2 2 -2 -3 -1 -5 -7
Net Change 0 0 0 0 0 0 0 0 1 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 1 1 2

Roopa Industries Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 48.03 48.03 48.03 48.03 48.03 48.03 48.03 48.03 48.03
Public 51.97 51.97 51.97 51.97 51.97 51.97 51.97 51.97 51.97
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Roopa Industries Ltd. Announcements

Fri, 22 Mar 2024
Closure of Trading Window
Intimation of closure of Trading Window for the quarter and year ended 31 March 2024.
Tue, 13 Feb 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of Newspaper Clippings with respect to unaudited financial results for the third quarter and nine months ended 31-12-2023.
Mon, 12 Feb 2024
Submission Of Unaudited Financial Results And Intimation Of Outcome Of The Board Meeting Held On 12Th February 2024
Submission of unaudited financial results and intimation of outcome of Board meeting held on 12th February 2024

Roopa Industries Ltd. Technical Scans

Thu, 28 Mar 2024
High Delivery Percentage High Delivery Percentage
Close Above Last Week High Close Above Last Week High
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months
High Increase in 1 Year High Increase in 1 Year

Roopa Industries Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 388,812.23 1,620.50 +0.8%
Cipla Ltd. 120,673.12 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. 102,679.14 6,171.85 +2.0%
Zydus Lifesciences Ltd. 101,151.67 1,007.35 +0.8%
Mankind Pharma Ltd. 92,029.19 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. 91,330.58 6,347.35 +1.9%
Divi's Laboratories Ltd. 91,234.91 3,452.55 +2.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 43.66 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-12 32.54 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.64 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 34.01 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-12 53.29 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.71 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-12 65.97 3,452.55 +2.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.23 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-12 4.66 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.82 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.37 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-12 10.36 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.52 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-12 7.00 3,452.55 +2.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 0.02 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,452.55 +2.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,452.55 +2.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,452.55 +2.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,452.55 +2.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,452.55 +2.6%

Roopa Industries Ltd. FAQ's

What is Roopa Industries share price?

Can I buy Roopa Industries shares now?

What is the Market Cap of Roopa Industries?

What are the key metrics to analyse Roopa Industries?

What is the 52 Week High and Low of Roopa Industries?

What is the trend of Roopa Industries share price?